Results 231 to 240 of about 542,868 (256)

Associations of Serum Urate and Cardiovascular Events in a Clinical Trial of Interleukin-1β Blockade. [PDF]

JACC Adv
Adamstein NH, MacFadyen JG, Weber BN, Libby P, Solomon DH, Ridker PM.   +5 more
europepmc   +1 more source

Serum amyloid a production in chicken embryonic synovial fibroblasts induced by lipopolysaccharide, interleukin-1β, and vitamin A. [PDF]

Poult Sci
Dayı B, Sevimli A, Akkoç A, Mutlu AM, Doğan N.   +4 more
europepmc   +1 more source

Erratum to "Plasma Proteomic Markers of Interleukin-1β Pathway Associated with Incident Age-Related Macular Degeneration in Persons with AIDS" [Ophthalmol Sci. 2025;5:100794]. [PDF]

Ophthalmol Sci
Hunt PW, Olshen AB, Murad N, Ambayec GC, Sezgin E, Schneider MF, Jabs DA.   +6 more
europepmc   +1 more source

Ischemic stroke is an instigator of cardiac dysfunction: the interleukin-1β pathway. [PDF]

Signal Transduct Target Ther
Schoenenberger-Berzins R, Schoenenberger AJ, Messerli FH.   +2 more
europepmc   +1 more source

Determination of perceived stress, salivary cortisol and interleukin-1β levels and clinical features of chronic urticaria in patients with dermographic urticaria in comparison to patients with chronic spontaneous urticaria and healthy individuals. [PDF]

Front Immunol
Lugović-Mihić L, Novak-Hlebar I, Smoljan D, Vukasović I, Barac E, Vilibić M.   +5 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Interleukins in cancer: from biology to therapy

Nature Reviews Cancer, 2021
Peter Libby, Daria Briukhovetska, Stefan Endres   +2 more
exaly  

gp130 AND THE INTERLEUKIN-6 FAMILY OF CYTOKINES

Annual Review of Immunology, 1997
Tadamitsu Kishimoto, Tetsuya Taga
exaly  

Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases

Nature Reviews Drug Discovery, 2012
Charles A. Dinarello, Anna Simon
exaly  

Residual inflammatory risk associated with interleukin-18 and interleukin-6 after successful interleukin-1β inhibition with canakinumab: further rationale for the development of targeted anti-cytokine therapies for the treatment of atherothrombosis

European Heart Journal, 2020
Tom Thuren, Peter Libby
exaly